Free tool
FAERS Monitor: Esbriet
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208780 or its brand name (Esbriet, Pirfenidone). Reports on generic versions are filed under their own applications.
Reports
40,844
Serious
22,668
55% of reports
Hospitalization
7,942
Death reported
9,477
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death7,558
- nausea5,186
- fatigue3,826
- diarrhoea3,309
- decreased appetite3,307
- dyspnoea3,004
- weight decreased2,261
- dizziness2,207
- cough2,093
- rash2,048
- vomiting1,819
- pneumonia1,794
- abdominal discomfort1,690
- headache1,530
- abdominal pain upper1,513
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 4 |
| 2010 | 15 |
| 2011 | 6 |
| 2012 | 13 |
| 2013 | 10 |
| 2014 | 123 |
| 2015 | 2,883 |
| 2016 | 4,177 |
| 2017 | 2,430 |
| 2018 | 4,311 |
| 2019 | 4,319 |
| 2020 | 5,096 |
| 2021 | 4,958 |
| 2022 | 4,745 |
| 2023 | 3,566 |
| 2024 | 1,930 |
| 2025 | 1,287 |
| 2026 | 971 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,013,315 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| decreased appetiteSignal | 3,307 | 7.4 | 7.2 | 18,315 |
| abdominal discomfortSignal | 1,690 | 5.2 | 5.0 | 5,766 |
| deathSignal | 7,558 | 4.5 | 4.5 | 21,624 |
| weight decreasedSignal | 2,261 | 4.2 | 4.0 | 5,531 |
| coughSignal | 2,093 | 3.9 | 3.7 | 4,468 |
| abdominal pain upperSignal | 1,513 | 3.8 | 3.6 | 3,133 |
| nauseaSignal | 5,186 | 3.4 | 3.3 | 9,018 |
| pneumoniaSignal | 1,794 | 2.9 | 2.7 | 2,196 |
| dyspnoeaSignal | 3,004 | 2.7 | 2.6 | 3,396 |
| diarrhoeaSignal | 3,309 | 2.6 | 2.6 | 3,482 |
| fatigueSignal | 3,826 | 2.5 | 2.5 | 3,684 |
| rashSignal | 2,048 | 2.4 | 2.3 | 1,744 |
| dizzinessSignal | 2,207 | 2.3 | 2.2 | 1,624 |
| vomiting | 1,819 | 2.0 | 1.9 | 920 |
| headache | 1,530 | 1.3 | 1.2 | 83 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.